Type II hypersensitivity

1,152,224views

Type II hypersensitivity

MRCP revision

MRCP revision

Acute intermittent porphyria
Autoimmune hemolytic anemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Sickle cell disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Anemia of chronic disease
Iron deficiency anemia
Sideroblastic anemia
Aplastic anemia
Immune thrombocytopenia
Polycythemia vera (NORD)
Antiphospholipid syndrome
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Hemophilia
Vitamin K deficiency
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Von Willebrand disease
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Paroxysmal nocturnal hemoglobinuria
Myelodysplastic syndromes
Myelofibrosis (NORD)
Acute leukemia
Chronic leukemia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Neuroblastoma
5-alpha-reductase deficiency
Androgen insensitivity syndrome
Congenital adrenal hyperplasia
Kallmann syndrome
Thyroglossal duct cyst
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Multiple endocrine neoplasia
Carcinoid syndrome
Hyperparathyroidism
Hypoparathyroidism
Hyperprolactinemia
Pituitary adenoma
Prolactinoma
Delayed puberty
Premature ovarian failure
Constitutional growth delay
Growth hormone deficiency
Hypopituitarism
Hypoprolactinemia
Pituitary apoplexy
Sheehan syndrome
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Thyroid eye disease (NORD)
Thyroid storm
Toxic multinodular goiter
Euthyroid sick syndrome
Postpartum thyroiditis
Riedel thyroiditis
Subacute granulomatous thyroiditis
Thyroid cancer
Bacillus cereus (Food poisoning)
Campylobacter jejuni
Clostridium difficile (Pseudomembranous colitis)
Escherichia coli
Helicobacter pylori
Listeria monocytogenes
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Shigella
Staphylococcus aureus
Vibrio cholerae (Cholera)
Yersinia enterocolitica
Coxsackievirus
Cytomegalovirus
Herpes simplex virus
Mumps virus
Ascending cholangitis
Gallstone ileus
Alcohol-associated liver disease
Alpha 1-antitrypsin deficiency
Budd-Chiari syndrome
Cholestatic liver disease
Cirrhosis
Gilbert's syndrome
Hemochromatosis
Hepatic encephalopathy
Viral hepatitis
Jaundice
Non-alcoholic fatty liver disease
Portal hypertension
Primary biliary cholangitis
Primary sclerosing cholangitis
Reye syndrome
Wilson disease
Acute pancreatitis
Chronic pancreatitis
Pancreatic pseudocyst
Hirschsprung disease
Intussusception
Ischemic colitis
Microscopic colitis
Necrotizing enterocolitis
Protein losing enteropathy
Short bowel syndrome (NORD)
Small bowel bacterial overgrowth syndrome
Small bowel ischemia and infarction
Tropical sprue
Volvulus
Whipple's disease
Autoimmune hepatitis
Celiac disease
Eosinophilic esophagitis (NORD)
Benign liver tumors
Hepatocellular adenoma
Hepatocellular carcinoma
Familial adenomatous polyposis
Juvenile polyposis syndrome
Peutz-Jeghers syndrome
Gastric cancer
Abdominal hernias
Achondroplasia
Developmental dysplasia of the hip
Muscular dystrophy
Osteomalacia and rickets
Osteoporosis
Paget disease of bone
Gout
Osteoarthritis
Compartment syndrome
Ankylosing spondylitis
Dermatomyositis
Juvenile idiopathic arthritis
Limited systemic sclerosis (CREST syndrome)
Mixed connective tissue disease
Polymyositis
Psoriatic arthritis
Raynaud phenomenon
Reactive arthritis
Rheumatoid arthritis
Sjogren syndrome
Systemic lupus erythematosus
Septic arthritis
Spondylitis
Baker cyst
Bursitis
Polymyalgia rheumatica
Temporomandibular joint dysfunction
Transient synovitis
Bone tumors
Fibromyalgia
Sciatica
Carpal tunnel syndrome
Rotator cuff tear
Prions (Spongiform encephalopathy)
Adenovirus
Eastern and Western equine encephalitis virus
Epstein-Barr virus (Infectious mononucleosis)
HIV (AIDS)
JC virus (Progressive multifocal leukoencephalopathy)
Lymphocytic choriomeningitis virus
Measles virus
Poliovirus
Rabies virus
Varicella zoster virus
West Nile virus
Cerebral palsy
Neurofibromatosis
Tuberous sclerosis
Erb-Duchenne palsy
Creutzfeldt-Jakob disease
Neurogenic bladder
Treponema pallidum (Syphilis)
Vitamin B12 deficiency
Acoustic neuroma (schwannoma)
Glaucoma
Amyloidosis
Focal segmental glomerulosclerosis (NORD)
Membranous nephropathy
Minimal change disease
Renal tubular acidosis
Nephroblastoma (Wilms tumor)
Non-urothelial bladder cancers
Transitional cell carcinoma
Renal cell carcinoma
Urinary incontinence
Renal cortical necrosis
Nephrotic syndromes: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Cardiac preload
Bacillus anthracis (Anthrax)
Bacteroides fragilis
Bordetella pertussis (Whooping cough)
Corynebacterium diphtheriae (Diphtheria)
Coxiella burnetii (Q fever)
Francisella tularensis (Tularemia)
Moraxella catarrhalis
Bacterial epiglottitis
Laryngomalacia
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Cytomegalovirus infection after transplant (NORD)
Graft-versus-host disease
Post-transplant lymphoproliferative disorders (NORD)
Transplant rejection
Anaphylaxis
Food allergy
Type I hypersensitivity
Hemolytic disease of the newborn
Pemphigus vulgaris
Type II hypersensitivity
Serum sickness
Type III hypersensitivity
Contact dermatitis
Type IV hypersensitivity
Atopic dermatitis
Lichen planus
Psoriasis
Erythema multiforme
Stevens-Johnson syndrome
Bullous pemphigoid
Acne vulgaris
Skin cancer

Flashcards

Type II hypersensitivity

0 of 15 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

A 50-year-old man is diagnosed with myasthenia gravis, a chronic autoimmune condition characterized as a type II hypersensitivity reaction. Which of the following best describes the underlying mechanism of this disease?

Transcript

Watch video only

Content Reviewers

Having a hypersensitivity means that the immune system is reacting to something in a way that damages the body rather than protecting it.

There are four different types of hypersensitivities, and the second type or type II hypersensitivity is sometimes called cytotoxic hypersensitivity because a lot of disorders caused by this hypersensitivity involve antibody mediated destruction of healthy cells.

These disorders tend to be tissue specific meaning that the antibodies are generally specific to one type of tissue or organ.

There are other antibody-mediated hypersensitivities that are systemic, and these are generally Type III hypersensitivities.

Our immune system is setup to fight anything that is considered “non-self” right? Anything that’s not “self”, or you.

This works in large part because of a process called central tolerance which is when developing immune cells that are self-reactive get destroyed or inactivated, whereas immune cells that aren’t are allowed to survive.

This happens while they are still in their primary lymphoid organs, which is the thymus for T cells and the bone marrow for B cells.

This process, though, is not perfect and some self-reactive B and T cells will escape.

These escaped self-reactive cells can then attack healthy tissue and result in autoimmune disease.

In type II hypersensitivity these escaped self-reactive B cells become activated and produce IgM or, with the help of CD4 positive T helper cells, IgG antibodies that attach to antigens on host cells.

There are two type of antigens involved with type II hypersensitivity: intrinsic meaning an antigen the host cell normally makes or extrinsic which is an antigen from an infection or even some medications, like penicillin that gets attached to the host cell.

Alright so let’s say a drug, like penicillin, binds to a red blood cell - well it becomes an extrinsic antigen.

An IgG or more rarely an IgM antibody that is penicillin specific might bind to the penicillin molecule, creating an antigen-antibody complex.

Now it’s worth mentioning that antigen-antibody complexes can happen in the course of a normal infection, but its when an antibody is complexed to host tissue, that things start to become a problem.

The first cytotoxic mechanism of type II hypersensitivity is activation of the complement system.

The complement system is a family of small proteins that work in an enzymatic cascade to fight off bacterial infections using a variety of mechanisms.

In this case, the IgG or IgM antibodies activate complement proteins which ultimately will kill the red blood cell bound to penicillin which is complexed now with IgG or IgM.

The process gets started when C1, the first of the complement proteins, which binds the Fc portion of the antibody.

C1 then engages other members of the complement family - C2 through C9, some of which are activated by being cleaved or chopped by an enzyme.

The cleaved fragments C3a, C4a, and C5a act as chemotactic factors, meaning they attract certain cells, in this case neutrophils.

Once neutrophils join the party, they degranulate or dump a bunch of enzymes like peroxidase, myeloperoxidase, and proteinase 3 which all help generate little oxygen radicals that are highly cytotoxic to cells and can cause tissue damage.

When it comes to drug reactions, like penicillin, Type II hypersensitivity can result in hemolytic anemia (sometimes called autoimmune hemolytic anemia), as well as thrombocytopenia, or neutropenia, since these are the blood cell types that are often affected.

This mechanism is also involved in diseases like Goodpasture’s syndrome, where antibodies bind to intrinsic antigens on collagen of the basement membrane in their glomeruli in the kidney or their alveoli in the lungs, rather than extrinsic antigens in the penicillin example.

The second cytotoxic mechanism requires us to follow the complement system through to the end, that said, C5b, and C6-C8, and a bunch of C9 come together to form the membrane attack complex, or MAC.

Key Takeaways

Type II hypersensitivity is a type of immune response in which the immune system attacks the body's own cells or tissues. Type II hypersensitivity is mediated by antibodies, such as IgG and IgM, directed against antigens on host cells, which cause cell and tissue destruction by complement activation or antibody-dependent cell-mediated cytotoxicity. Examples of Type II hypersensitivity reactions include blood transfusion reactions, erythroblastosis fetalis, and autoimmune hemolytic anemia. Treatment options may include avoiding the tigger, and immunosuppressive medications such as systemic glucocorticoids.